Icario, the healthcare industry’s leading engagement company, today announced it has named Dr. Robert Mirsky as Chief Medical Officer, reporting to CEO Marc Willard. In this position, Mirsky will bring his strategic, clinical and operational expertise to continued development of the company’s new platform.
“Dr. Mirsky has deep expertise in care management, population health, and value-based care, and is the right person to help bring our new digital first, quality and health outcomes-focused, omni-channel member engagement platform to the market. We know he will not only help us accelerate our ability to address health plan challenges but also equip them with an intuitive, API-based, foundation to seamlessly integrate with their broader member experience ecosystem.” said Marc Willard, Chief Executive Officer at Icario.
Dr. Mirsky joins Icario with more than 20 years of extensive health plan experience across Medicare and Medicaid. He has spent the past several years bringing his expertise to early-stage health care companies. Prior to that, he served as Vice President, Medical Operations and Chief Medical Officer Medicare for Aetna. During his time there, he was responsible for driving operational excellence and best-in-class care management through medical management, provider collaboration, network strategy, and medical economics.
“I’m joining an organization whose mission I’m deeply passionate about,” Mirsky said, “Seniors thrive when we address medical, emotional and social determinants of health with a focus on ensuring that they receive the care they need,” Mirsky said. “With continued AI and machine learning, Icario is perfectly poised to ultimately nudge the right behaviors at the right time. Today’s seniors are much more technologically savvy than their predecessors and we need new and better ways to reach them. With the upcoming launch of this new platform, this group will be further positioned to be the leader in not only patient engagement, but in the kind of data health plan’s need to make population-level decisions about programs and patient outreach.”
